StockData
60 Degrees Pharmaceuticals, Inc. logo

60 Degrees Pharmaceuticals, Inc. (SXTP) stock

SXTPNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SXTPW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 8/3060% below fair value
$0.53+0.04 (+8.14%)

Close on Nov 17, 2026Market cap $1.88MP/E –Yield –

60 Degrees Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for 60 Degrees Pharmaceuticals

60 Degrees Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More 60 Degrees Pharmaceuticals figures

See a number that looks wrong?